메뉴 건너뛰기




Volumn 34, Issue 3, 2011, Pages 442-444

Renal artery denervation for the treatment of hypertension: Opening up new horizons

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

EID: 79959618984     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-011-0129-7     Document Type: Note
Times cited : (5)

References (18)
  • 1
    • 60449094498 scopus 로고    scopus 로고
    • Heart disease and stroke statistics - 2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
    • Lloyd-Jones D, Adams R, Carnethon M et al (2009) Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119:480-486
    • (2009) Circulation , vol.119 , pp. 480-486
    • Lloyd-Jones, D.1    Adams, R.2    Carnethon, M.3
  • 2
    • 12344282783 scopus 로고    scopus 로고
    • Global burden of hypertension: Analysis of worldwide data
    • DOI 10.1016/S0140-6736(05)17741-1, PII S0140673605177411
    • Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365:217-223 (Pubitemid 40138015)
    • (2005) Lancet , vol.365 , Issue.9455 , pp. 217-223
    • Kearney, P.M.1    Whelton, M.2    Reynolds, K.3    Muntner, P.4    Whelton, P.K.5    He, J.6
  • 3
    • 0141836163 scopus 로고    scopus 로고
    • Balloon angioplasty versus medical therapy for hypertensive patients with renal artery obstruction
    • CD002944
    • Nordmann AJ, Logan AG (2003) Balloon angioplasty versus medical therapy for hypertensive patients with renal artery obstruction. Cochrane Database Syst Rev CD002944
    • (2003) Cochrane Database Syst Rev
    • Nordmann, A.J.1    Logan, A.G.2
  • 4
    • 0037314935 scopus 로고    scopus 로고
    • Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: A meta-analysis of randomized trials
    • DOI 10.1093/ndt/18.2.298
    • Ives NJ, Wheatley K, Stowe RL et al (2003) Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol Dial Transplant 18:298-304 (Pubitemid 36181680)
    • (2003) Nephrology Dialysis Transplantation , vol.18 , Issue.2 , pp. 298-304
    • Ives, N.J.1    Wheatley, K.2    Stowe, R.L.3    Krijnen, P.4    Plouin, P.-F.5    Van Jaarsveld, B.C.6    Gray, R.7
  • 7
    • 0842267844 scopus 로고    scopus 로고
    • The sympathetic nervous system and hypertension: Recent developments
    • DiBona GF (2004) The sympathetic nervous system and hypertension: recent developments. Hypertension 43:147-150
    • (2004) Hypertension , vol.43 , pp. 147-150
    • DiBona, G.F.1
  • 8
    • 0031015981 scopus 로고    scopus 로고
    • Neural control of renal function
    • DiBona GF, Kopp UC (1997) Neural control of renal function. Physiol Rev 77:75-197
    • (1997) Physiol Rev , vol.77 , pp. 75-197
    • DiBona, G.F.1    Kopp, U.C.2
  • 9
    • 75349085866 scopus 로고    scopus 로고
    • Renal sympathetic denervation and systemic hypertension
    • Doumas M, Faselis C, Papademetriou V (2010) Renal sympathetic denervation and systemic hypertension. Am J Cardiol 105:570-576
    • (2010) Am J Cardiol , vol.105 , pp. 570-576
    • Doumas, M.1    Faselis, C.2    Papademetriou, V.3
  • 10
    • 77249109872 scopus 로고    scopus 로고
    • Renal sympathetic nerve ablation: The new frontier in the treatment of hypertension
    • Schlaich MP, Krum H, Sobotka PA (2010) Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension. Curr Hypertens Rep 12:39-46
    • (2010) Curr Hypertens Rep , vol.12 , pp. 39-46
    • Schlaich, M.P.1    Krum, H.2    Sobotka, P.A.3
  • 11
    • 8244254072 scopus 로고
    • Effect of thoracolumbar sympathectomy on the clinical course of primary (essential) hypertension. A ten-year study of 100 sympathectomized patients compared with individually matched, symptomatically treated control subjects
    • Evelyn KA, Singh MM, Chapman WP, Perera GA, Thaler H (1960) Effect of thoracolumbar sympathectomy on the clinical course of primary (essential) hypertension. A ten-year study of 100 sympathectomized patients compared with individually matched, symptomatically treated control subjects. Am J Med 28:188-221
    • (1960) Am J Med , vol.28 , pp. 188-221
    • Evelyn, K.A.1    Singh, M.M.2    Chapman, W.P.3    Perera, G.A.4    Thaler, H.5
  • 12
    • 50449148274 scopus 로고
    • Sympathectomy in the treatment of hypertension; review of 122 cases
    • Morrissey DM, Brookes VS, Cooke WT (1953) Sympathectomy in the treatment of hypertension; review of 122 cases. Lancet 1:403-408
    • (1953) Lancet , vol.1 , pp. 403-408
    • Morrissey, D.M.1    Brookes, V.S.2    Cooke, W.T.3
  • 13
    • 0000220091 scopus 로고
    • Splanchnicectomy for essential hypertension; results in 1,266 cases
    • Smithwick RH, Thompson JE (1953) Splanchnicectomy for essential hypertension; results in 1,266 cases. JAMA 152:1501-1504
    • (1953) JAMA , vol.152 , pp. 1501-1504
    • Smithwick, R.H.1    Thompson, J.E.2
  • 14
    • 64049084640 scopus 로고    scopus 로고
    • Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study
    • Krum H, Schlaich M, Whitbourn R et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373:1275-1281
    • (2009) Lancet , vol.373 , pp. 1275-1281
    • Krum, H.1    Schlaich, M.2    Whitbourn, R.3
  • 15
    • 78649876825 scopus 로고    scopus 로고
    • Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial
    • Symplicity HTN-2 Investigators doi:10.1016/S0140-6736(10)62039-9
    • Symplicity HTN-2 Investigators (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet doi:10.1016/S0140-6736(10)62039-9
    • (2010) Lancet
  • 16
    • 78649348376 scopus 로고    scopus 로고
    • Two-year durability of blood pressure reduction with catheter-based renal sympathetic denervation
    • Schlaich M, Krum H, Walton A, Whitbourn R, Sobotka PA, Esler M (2010) Two-year durability of blood pressure reduction with catheter-based renal sympathetic denervation. J Hypertens 28(Suppl A):446
    • (2010) J Hypertens , vol.28 , Issue.SUPPL. A , pp. 446
    • Schlaich, M.1    Krum, H.2    Walton, A.3    Whitbourn, R.4    Sobotka, P.A.5    Esler, M.6
  • 18
    • 79959584531 scopus 로고    scopus 로고
    • Renal sympathetic denervation: The jury is still out
    • in press
    • Doumas M, Douma S (2011) Renal sympathetic denervation: the jury is still out. Lancet (in press)
    • (2011) Lancet
    • Doumas, M.1    Douma, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.